152 reports of this reaction
1.8% of all DECITABINE reports
#17 most reported adverse reaction
PANCYTOPENIA is the #17 most commonly reported adverse reaction for DECITABINE, manufactured by Accord Healthcare Inc.. There are 152 FDA adverse event reports linking DECITABINE to PANCYTOPENIA. This represents approximately 1.8% of all 8,659 adverse event reports for this drug.
Patients taking DECITABINE who experience pancytopenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PANCYTOPENIA is a less commonly reported adverse event for DECITABINE, but still significant enough to appear in the safety profile.
In addition to pancytopenia, the following adverse reactions have been reported for DECITABINE:
The following drugs have also been linked to pancytopenia in FDA adverse event reports:
PANCYTOPENIA has been reported as an adverse event in 152 FDA reports for DECITABINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PANCYTOPENIA accounts for approximately 1.8% of all adverse event reports for DECITABINE, making it a notable side effect.
If you experience pancytopenia while taking DECITABINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.